WAM
AST

Wealthspire Advisors (Maryland)’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-124
Closed – – 2694
2018
Q4 		$0 Hold
124
– – ﹤0.01% 2695
2018
Q3 		$0 Hold
124
– – ﹤0.01% 2634
2018
Q2 		$0 Hold
124
– – ﹤0.01% 2714
2018
Q1 		$0 Hold
124
– – ﹤0.01% 2766
2017
Q4 		$0 Hold
124
– – ﹤0.01% 2673
2017
Q3 		$0 Hold
124
– – ﹤0.01% 2650
2017
Q2 		$0 Buy
+124
New +$409 ﹤0.01% 2387

Wealthspire Advisors (Maryland)'s AST Position: Q1 2019 in Review

Wealthspire Advisors (Maryland) sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 124 shares.

Wealthspire Advisors (Maryland) first reported a position in AST in Q2 2017 and held it in 7 quarters. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 124 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Wealthspire Advisors (Maryland) first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2019, filed 13 May 2019.